Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.

Mehmet Kayaalp Abdulsamet Erden Hakan Apaydın Serdar Can Güven Armagan Berkan Merve Cağlayan Kayaalp Esma Andac Uzdogan Şeymanur Ala Enli Ahmet Omma Orhan Kücüksahin

Published in: Laboratory medicine (2023)

Our study suggests that Sema3A may play a significant role in the pathogenesis of vasculopathy and can be used as a biomarker in SSc patients with vascular complications such as DU and PAH.

Keyphrases

systemic sclerosis
interstitial lung disease
risk factors
rheumatoid arthritis
idiopathic pulmonary fibrosis